Literature DB >> 11782399

Beta-catenin, MAPK and Smad signaling during early Xenopus development.

Anne Schohl1, François Fagotto.   

Abstract

Knowledge of when and where signaling pathways are activated is crucial for understanding embryonic development. In this study, we have systematically analyzed and compared the signaling pattern of four major pathways by localization of the activated key components beta-catenin (Wnt proteins), MAPK (tyrosine kinase receptors/FGF), Smad1 (BMP proteins) and Smad2 (Nodal/activin/Vg1). We have determined semi-quantitatively the distribution of these components at 18 consecutive stages in Xenopus development, from early blastula to tailbud stages, by immunofluorescence on serial cryosections. The image obtained is that of very dynamic and widespread activities, with very few inactive regions. Signaling fields can vary from large gradients to restricted areas with sharp borders. They do not respect tissue boundaries. This direct visualization of active signaling verifies several predictions inferred from previous functional data. It also reveals unexpected signal patterns, pointing to some poorly understood aspects of early development. In several instances, the patterns strikingly overlap, suggesting extensive interplay between the various pathways. To test this possibility, we have manipulated maternal beta-catenin signaling and determined the effect on the other pathways in the blastula embryo. We found that the patterns of P-MAPK, P-Smad1 and P-Smad2 are indeed strongly dependent on beta-catenin at this stage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782399     DOI: 10.1242/dev.129.1.37

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  84 in total

1.  Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation in neural induction.

Authors:  Edgar M Pera; Atsushi Ikeda; Edward Eivers; Eddy M De Robertis
Journal:  Genes Dev       Date:  2003-12-15       Impact factor: 11.361

2.  A role for maternal beta-catenin in early mesoderm induction in Xenopus.

Authors:  Anne Schohl; François Fagotto
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

Review 3.  The ins and outs of APC and beta-catenin nuclear transport.

Authors:  Beric R Henderson; Francois Fagotto
Journal:  EMBO Rep       Date:  2002-09       Impact factor: 8.807

4.  Dynamics of TGF-β signaling reveal adaptive and pulsatile behaviors reflected in the nuclear localization of transcription factor Smad4.

Authors:  Aryeh Warmflash; Qixiang Zhang; Benoit Sorre; Alin Vonica; Eric D Siggia; Ali H Brivanlou
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

5.  Smurf1 regulates neural patterning and folding in Xenopus embryos by antagonizing the BMP/Smad1 pathway.

Authors:  Evguenia M Alexandrova; Gerald H Thomsen
Journal:  Dev Biol       Date:  2006-08-10       Impact factor: 3.582

6.  Morphogen gradient interpretation by a regulated trafficking step during ligand-receptor transduction.

Authors:  Jerome Jullien; John Gurdon
Journal:  Genes Dev       Date:  2005-10-31       Impact factor: 11.361

7.  Default neural induction: neuralization of dissociated Xenopus cells is mediated by Ras/MAPK activation.

Authors:  Hiroki Kuroda; Luis Fuentealba; Atsushi Ikeda; Bruno Reversade; E M De Robertis
Journal:  Genes Dev       Date:  2005-05-01       Impact factor: 11.361

8.  Chordin forms a self-organizing morphogen gradient in the extracellular space between ectoderm and mesoderm in the Xenopus embryo.

Authors:  Jean-Louis Plouhinec; Lise Zakin; Yuki Moriyama; Edward M De Robertis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-27       Impact factor: 11.205

9.  PI3K and Erk MAPK mediate ErbB signaling in Xenopus gastrulation.

Authors:  Shuyi Nie; Chenbei Chang
Journal:  Mech Dev       Date:  2007-07-19       Impact factor: 1.882

10.  Fgf8a induces neural crest indirectly through the activation of Wnt8 in the paraxial mesoderm.

Authors:  Chang-Soo Hong; Byung-Yong Park; Jean-Pierre Saint-Jeannet
Journal:  Development       Date:  2008-12       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.